These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 17273614)

  • 1. Cellular and biochemical bases of chronic obstructive pulmonary disease.
    Rufino R; Lapa e Silva JR
    J Bras Pneumol; 2006; 32(3):241-8. PubMed ID: 17273614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [New concepts in the pathogenesis and pathophysiology of COPD].
    Fira-Mladinescu O; Tudorache V; Mihăicută S; Muntean D
    Pneumologia; 2007; 56(1):24, 26-31. PubMed ID: 17491205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic obstructive pulmonary disease: effects beyond the lungs.
    Balasubramanian VP; Varkey B
    Curr Opin Pulm Med; 2006 Mar; 12(2):106-12. PubMed ID: 16456379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pathogenesis of the chronic obstructive pulmonary disease (COPD)].
    Musil J
    Vnitr Lek; 2004 Sep; 50(9):663-7. PubMed ID: 15580897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenesis of chronic obstructive pulmonary disease.
    Macnee W
    Clin Chest Med; 2007 Sep; 28(3):479-513, v. PubMed ID: 17720039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidative stress in pathogenesis of chronic obstructive pulmonary disease: cellular and molecular mechanisms.
    Rahman I
    Cell Biochem Biophys; 2005; 43(1):167-88. PubMed ID: 16043892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Local inflammation occurs before systemic inflammation in patients with COPD.
    He Z; Chen Y; Chen P; Wu G; Cai S
    Respirology; 2010 Apr; 15(3):478-84. PubMed ID: 20210891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional significance of apoptosis in chronic obstructive pulmonary disease.
    Park JW; Ryter SW; Choi AM
    COPD; 2007 Dec; 4(4):347-53. PubMed ID: 18027162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary and systemic oxidant/antioxidant imbalance in chronic obstructive pulmonary disease.
    MacNee W
    Proc Am Thorac Soc; 2005; 2(1):50-60. PubMed ID: 16113469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The nature of small-airway obstruction in chronic obstructive pulmonary disease.
    Hogg JC; Chu F; Utokaparch S; Woods R; Elliott WM; Buzatu L; Cherniack RM; Rogers RM; Sciurba FC; Coxson HO; Paré PD
    N Engl J Med; 2004 Jun; 350(26):2645-53. PubMed ID: 15215480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [More research is needed to understand the airway inflammation in chronic obstructive pulmonary disease].
    He P
    Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(30):2089-91. PubMed ID: 19080465
    [No Abstract]   [Full Text] [Related]  

  • 12. Current perspectives of oxidative stress and its measurement in chronic obstructive pulmonary disease.
    Lin JL; Thomas PS
    COPD; 2010 Aug; 7(4):291-306. PubMed ID: 20673039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathophysiology of exacerbations of chronic obstructive pulmonary disease.
    Papi A; Luppi F; Franco F; Fabbri LM
    Proc Am Thorac Soc; 2006 May; 3(3):245-51. PubMed ID: 16636093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular and molecular mechanisms of chronic obstructive pulmonary disease.
    Barnes PJ
    Clin Chest Med; 2014 Mar; 35(1):71-86. PubMed ID: 24507838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Neutrophils and macrophages related to the pathogenesis and disease development of chronic obstructive pulmonary disease by the inflammatory reaction].
    Ohbayashi O; Takizawa H
    Nihon Rinsho; 2011 Oct; 69(10):1741-7. PubMed ID: 22073566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aerobic capacity, oxidant stress, and chronic obstructive pulmonary disease--a new take on an old hypothesis.
    Stevenson CS; Koch LG; Britton SL
    Pharmacol Ther; 2006 Apr; 110(1):71-82. PubMed ID: 16343638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cells, mediators and Toll-like receptors in COPD.
    Sarir H; Henricks PA; van Houwelingen AH; Nijkamp FP; Folkerts G
    Eur J Pharmacol; 2008 May; 585(2-3):346-53. PubMed ID: 18410916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of cellular and biochemical markers of airway inflammation in patients with mild-to-moderate asthma and chronic obstructive pulmonary disease: an induced sputum and bronchoalveolar lavage fluid study.
    Gorska K; Krenke R; Domagala-Kulawik J; Korczynski P; Nejman-Gryz P; Kosciuch J; Hildebrand K; Chazan R
    J Physiol Pharmacol; 2008 Dec; 59 Suppl 6():271-83. PubMed ID: 19218651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular and molecular mechanisms in chronic obstructive pulmonary disease: an overview.
    Di Stefano A; Caramori G; Ricciardolo FL; Capelli A; Adcock IM; Donner CF
    Clin Exp Allergy; 2004 Aug; 34(8):1156-67. PubMed ID: 15298554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pathogenesis of chronic obstructive pulmonary disease. Cellular mechanisms (part I)].
    Mróz RM; Szulakowski P; Pierzchala W; Chyczewska E; MacNee W
    Wiad Lek; 2006; 59(1-2):92-6. PubMed ID: 16646301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.